These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 505693

  • 1. [Orbicin (dibekacin sulfate)].
    Hofstetter A.
    Urologe A; 1979 Nov; 18(6):355-7. PubMed ID: 505693
    [No Abstract] [Full Text] [Related]

  • 2. [Value of orbicin iv infusions in severe surgical infections. Serum level and clinical effect].
    Moorthi K, Ghobadi M, Schroer H.
    Med Welt; 1980 Aug 22; 31(34):1209-10. PubMed ID: 6776380
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of surgical infections with dibekacin. Pharmacokinetic, clinical and bacteriological results].
    Sievers U, von Kobyletzki D, Primavesi CA.
    Fortschr Med; 1980 Nov 13; 98(42):1667-70. PubMed ID: 7461562
    [Abstract] [Full Text] [Related]

  • 4. [Clinical studies on combination chemotherapy with fosfomycin and dibekacin in complicated urinary tract infection].
    Amano M, Okunobo T, Ueda H, Ura H, Sone A, Furukawa Y, Saito N, Tanaka H.
    Hinyokika Kiyo; 1983 Aug 13; 29(8):947-52. PubMed ID: 6675445
    [Abstract] [Full Text] [Related]

  • 5. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M, Brun Y, Forey F, Fleurette J.
    Nouv Presse Med; 1982 Nov 18; 11(46):3391-5. PubMed ID: 7155846
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Dibekacin in the treatment of urinary infections in the elderly].
    Lopitaux R, Hermet R, Sirot J, Cluzel M.
    Pathol Biol (Paris); 1984 Jun 18; 32(5 Pt 2):563-6. PubMed ID: 6462747
    [Abstract] [Full Text] [Related]

  • 8. How can DKB and tobramycin be inactivated on two different sites by the same enzyme?
    Le Goffic F, Moreau N, Soussy CJ, Duval J.
    Ann Microbiol (Paris); 1977 Jun 18; 128B(4):459-63. PubMed ID: 610500
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Resistance testing in general practice--is it valid?].
    Bjerrum L, Grinsted P, Petersen PH, Søgaard P.
    Ugeskr Laeger; 2000 Aug 28; 162(35):4660-2. PubMed ID: 10986893
    [Abstract] [Full Text] [Related]

  • 12. Some problems of systemic antimicrobial therapy.
    Chourashy BK.
    J Indian Med Assoc; 1981 Jun 16; 76(12):227-9. PubMed ID: 7343615
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [In vitro antibacterial activity of dibekacin on staphylococci, streptococci and aerobic Gram negative bacilli].
    Deforges L, Van Thoi J, Le Soussy CJ, Duval J.
    Nouv Presse Med; 1982 Nov 18; 11(46):3385-90. PubMed ID: 7155845
    [Abstract] [Full Text] [Related]

  • 19. [Shorten time of treatment in lower urinary tract infection in women and don't use quinolones!].
    Cars O, Struwe J, Norman C, Sandberg T.
    Lakartidningen; 1982 Nov 18; 105(15):1114-5. PubMed ID: 18561756
    [No Abstract] [Full Text] [Related]

  • 20. [Serum concentrations and clinical efficacy of dibekacin after intravenous drip infusion to patients with respiratory tract infections].
    Soejima R, Niki Y, Matsushima T, Tano Y.
    Jpn J Antibiot; 1982 Dec 18; 35(12):2773-7. PubMed ID: 7182533
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.